3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one

Basic Information

View in Editor

CAS Number

82543-15-5

Molecular Formula

C20H28O3

Molecular Weight

316.44 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Melting Point

199-203°C (dec.)

Boiling Point

467.26 °C at 760 mmHg

Density

1.258

Flash Point

467.26 °C at 760 mmHg

SMILES

View in Editor

CC12CCC(CC1(C=CC3C2CCC4(C3C5CC5C4=O)C)O)O

InChI

InChI=1S/C20H28O3/c1-18-6-5-15-12(16(18)13-9-14(13)17(18)22)4-8-20(23)10-11(21)3-7-19(15,20)2/h4,8,11-16,21,23H,3,5-7,9-10H2,1-2H3/t11-,12+,13+,14-,15-,16+,18-,19+,20-/m0/s1

InChIKey

IYCDFUCBUZDDIU-MBYPHNFESA-N

LogP

2.7059000000000006

Topological Polar Surface Area

57.53 Å²

Hydrogen Bond Donor/Acceptor

2 / 3

Complexity

612

Synonyms & References

English

3beta,5beta-dihydroxy-15alpha,16alpha-methylene-androst-6-en-17-one
CS-0158287
3
SCHEMBL856974
3beta,5-Dihydroxy-15beta,16beta-methylene-5beta-androst-6-en-17-one
D95108
3 ,5 -Dihydroxy-15 ,16 -methylene-androst-6-en-17-one
3I(2),5I(2)-Dihydroxy-15I(2),16I(2)-methylene-androst-6-en-17-one
3?,5?-Dihydroxy-15?,16?-methylene-5 ?-androst-6-en-17-one
A,5
IYCDFUCBUZDDIU-MBYPHNFESA-N
EC 617-346-9
AKOS016002260
82543-15-5
AC-28720
NS00011525
3beta,5beta-dihydroxy-15beta,16beta-methyleneandrost-6-en-17-one
A-dihydroxy-15
Q-102811
(1R,2S,3S,5S,7S,10S,11R,14S,16R)-14,16-dihydroxy-7,11-dimethylpentacyclo[8.8.0.02,7.03,5.011,16]octadec-17-en-6-one
(2S,4aR,4bS,6aS,7aS,8aS,8bS,10aR)-2,10a-Dihydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,10a-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one
(3b,5b,15a,16a)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one
3b,5-Dihydroxy-15b,16b-methylene-5b-androst-6-en-17-one
3'H-Cycloprop[15,16]androsta-6,15-dien-17-one, 15,16-dihydro-3,5-dihydroxy-, (3?,5?,15?,16?)-; 3?,5-Dihydroxy-15?,16?-methylene-5?-androst-6-en-17-one
2-(4-(4-NITROPHENOXY)PHENYL)ACETICACID
3????,5????-Dihydroxy-15????,16????-methylene-androst-6-en-17-one
3beta,5-Dihydroxy-15beta,16beta-methylen-5beta-androst-6-en-17-one
3'H-Cycloprop[15,16]androsta-6,15-dien-17-one,15,16-dihydro-3,5-dihydroxy-, (3b,5b,15a,16a)-
A864390
3 beta,5 beta-Dihydroxy-15 beta,16 beta-methylene-5 beta-androst-6-en-17-one
DS-14178

MDL Number

MFCD12407189

FAQ

What regulatory guidelines apply to 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5)?

3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5) is subject to various regulatory guidelines, including GHS classification for hazardous substances, REACH regulations for the registration, evaluation, authorization, and restriction of chemicals in the European Union, and FDA/EPA requirements for the use in pharmaceuticals and environmental management, respectively. It is important to consult the relevant regulatory authorities for specific guidelines applicable to your region.

Are there alternatives to 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5) in synthesis?

Several alternatives to 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5) exist in synthesis, including its isomers and analogs such as 3β-hydroxy-17-one and 15α,16α-dimethyl-3β-hydroxyandrost-6-en-17-one. Common alternative reagents may include steroidal precursors and various steroid intermediates, which can serve as effective substitutes depending on the specific synthesis requirements.

What is the market or research trend for 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5)?

The market and research trends for 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5) are closely tied to its applications in pharmaceuticals, particularly in hormone therapy and as a precursor for steroid synthesis. Recent research focuses on its potential in treating hormonal disorders and its role in drug development. Market trends indicate increasing demand due to its bioavailability and therapeutic potential.

How should waste containing 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5) be handled?

Waste containing 3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one (CAS: 82543-15-5) should be handled according to local and national waste management regulations. Collection of waste liquids should be done using appropriate containers, and incineration or professional waste disposal services should be employed. Environmental protection measures include ensuring no spillage and proper containment to prevent contamination of soil and water. Always consult the Material Safety Data Sheet (MSDS) and local authorities for specific handling instructions.